TherapeuticsMD, Inc.
TXMD US88338N2062
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -71% | -72% | -64% | -63% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Thompson Tommy G |
1.00 USD |
325 Bought |
326 USD |
14/04/2025 | 14/04/2025 |
| Walker Marlan D CEO |
1.00 USD |
490 Bought |
489 USD |
14/04/2025 | 14/04/2025 |
| Walker Marlan D CEO |
0.86 USD |
1,167 Bought |
1,000 USD |
09/04/2025 | 10/04/2025 |
| Walker Marlan D CEO |
0.87 USD |
1,136 Bought |
994 USD |
09/04/2025 | 09/04/2025 |
| Collins Cooper C. |
1.73 USD |
4,094 Bought |
7,099 USD |
22/08/2024 | 22/08/2024 |
| Collins Cooper C. |
1.70 USD |
1,200 Bought |
2,039 USD |
21/08/2024 | 21/08/2024 |
| Walker Marlan D CEO |
2.24 USD |
4,550 Sold |
10,187 USD |
05/12/2023 | 07/12/2023 |
| Walker Marlan D CEO |
2.31 USD |
14,500 Sold |
33,496 USD |
05/12/2023 | 06/12/2023 |